Home/Filings/4/0001578563-25-000312
4//SEC Filing

Bartholdson John A. 4

Accession 0001578563-25-000312

CIK 0001665988other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 9:22 AM ET

Size

11.4 KB

Accession

0001578563-25-000312

Insider Transaction Report

Form 4
Period: 2025-06-02
Bartholdson John A.
Director10% Owner
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-06-0226,4930 total
    Class A Common Stock (26,493 underlying)
  • Award

    Restricted Stock Units

    2025-06-03+32,28232,282 total
    Class A Common Stock (32,282 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-06-02+26,49372,045 total
Holdings
  • Class A Common Stock

    (indirect: See Footnotes)
    6,939,357
Footnotes (5)
  • [F1]Consists of (i) 4,624,431 shares of Class A Common Stock held by Juniper Targeted Opportunity Fund, L.P. ("Juniper Fund"), (ii) 2,239,076 shares of Class A Common Stock held by Juniper Targeted Opportunities, L.P. ("Juniper Targeted Opportunities"), and (iii) 75,850 shares of Class A Common Stock held by Juniper Multi-Strategy Fund, L.P. ("Juniper Multi-Strategy" and, together with Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, the "Juniper Entities").
  • [F2]Juniper HF Investors II, LLC ("Juniper HF II"), Juniper Targeted Opportunity Investors, LLC ("Juniper TO") and Juniper HF Investors, LLC ("Juniper HF") are each the general partner of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, respectively. Juniper Investment Company, LLC ("Juniper Investment Company") provides investment advisory and management services and acts as the investment manager of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy. The Reporting Person is a managing member of Juniper Investment Company, Juniper HF II, Juniper TO and Juniper HF and shares voting and dispositive power with respect to the shares held by the Juniper Entities. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
  • [F3]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
  • [F4]The RSUs vested on June 2, 2025.
  • [F5]The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Issuer

Bioventus Inc.

CIK 0001665988

Entity typeother

Related Parties

1
  • filerCIK 0001382909

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 9:22 AM ET
Size
11.4 KB